Healthcare Today Fiji: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Fiji.

Press releases published on August 27, 2026

4 hours ago

Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure

Indeterminate GlobeNewswire

4 hours ago

HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results

Indeterminate GlobeNewswire

4 hours ago

Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027

Indeterminate GlobeNewswire

4 hours ago

Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany

Indeterminate GlobeNewswire

4 hours ago

Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting

Indeterminate GlobeNewswire

4 hours ago

Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor

Indeterminate GlobeNewswire

4 hours ago

Entera to Participate in Upcoming Fall Investor Conferences

Indeterminate GlobeNewswire

4 hours ago

Eascra Biotech Awarded $7.96 Million NASA InSPA Phase 2 Contract to Advance Space-Manufactured Nanomedicine

Indeterminate GlobeNewswire

4 hours ago

Eascra Biotech Appoints Chief Scientific Officer to Lead Commercialization Push

Indeterminate GlobeNewswire

4 hours ago

Bioprinting Market to Reach $5.1 Billion by 2030, Driven by Regenerative Medicine Demand and AI Integration

Indeterminate GlobeNewswire

4 hours ago

BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation

Indeterminate GlobeNewswire

4 hours ago

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial

Indeterminate GlobeNewswire

4 hours ago

Nexalin Technology Announces Reverse Stock Split

Indeterminate GlobeNewswire

5 hours ago

HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System

Indeterminate GlobeNewswire

5 hours ago

NovaBridge Biosciences to Participate in September Investor Conferences

Indeterminate GlobeNewswire

5 hours ago

Velocity Clinical Research Establishes a New Industry Benchmark, Entering 97% of Patient Data Within 24 Hours of Collection

Indeterminate GlobeNewswire

5 hours ago

Korro to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

5 hours ago

Aveanna to Participate in the Deutsche Bank 2026 Healthcare Summit

Indeterminate GlobeNewswire

5 hours ago

Slate Medicines Announces First Participant Dosed in Phase 1 Study Evaluating SLTE-1009

Indeterminate GlobeNewswire

5 hours ago

NetraMark to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire